\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationZeebrugge, Belgium
ProgrammesThe Belgian Navy Hackathon is an Open Innovation event. It brings together Navy personnel and civilian professionals, representing the entire Belgian maritime ecosystem.
On September 24 and 25, participants will work in small, multidisciplinary groups to imagine, develop, and pitch projects for solving concrete, urgent challenges identified jointly by the Navy and the maritime ecosystem.
Winning projects will be presented during Captains of Industry Day at TECHNOFest 2024 on October 4.
Four challenges for this hackathon have been identified by the Navy staff and validated by representatives of the maritime ecosystem in four workshops.
Solving these hard challenges will take the knowledge and experience of dozens of people, and of course your fresh perspective, your ingenuity, and your ability to think creatively and strategically.
Anti-drone measures
Public Awareness for Accelerating Recruitment
Resilience of the Logistical Infrastructure
More information and registration: https://inno4def.be/nh24/
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
